Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979–2015
出版年份 2017 全文链接
标题
Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979–2015
作者
关键词
-
出版物
PEDIATRIC DRUGS
Volume 19, Issue 6, Pages 577-593
出版商
Springer Nature
发表日期
2017-08-07
DOI
10.1007/s40272-017-0251-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Advances in emerging drugs for the treatment of neuroblastoma
- (2017) Pablo Berlanga et al. EXPERT OPINION ON EMERGING DRUGS
- Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
- (2017) Ruth Ladenstein et al. LANCET ONCOLOGY
- More than the genes, the tumor microenvironment in neuroblastoma
- (2016) Lucia Borriello et al. CANCER LETTERS
- Socioeconomic status and global variations in the incidence of neuroblastoma: call for support of population-based cancer registries in low-middle-income countries
- (2016) Junne Kamihara et al. PEDIATRIC BLOOD & CANCER
- Childhood Neuroblastoma: Incidence and Survival in Argentina. Report from the National Pediatric Cancer Registry, ROHA Network 2000-2012
- (2016) Florencia Moreno et al. PEDIATRIC BLOOD & CANCER
- Neuroblastoma: Molecular Pathogenesis and Therapy
- (2015) Chrystal U. Louis et al. Annual Review of Medicine
- Tandem high-dose chemotherapy with thiotepa and busulfan–melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients
- (2015) C Pasqualini et al. BONE MARROW TRANSPLANTATION
- Advances in Risk Classification and Treatment Strategies for Neuroblastoma
- (2015) Navin R. Pinto et al. JOURNAL OF CLINICAL ONCOLOGY
- Telomerase activation by genomic rearrangements in high-risk neuroblastoma
- (2015) Martin Peifer et al. NATURE
- Mutational dynamics between primary and relapse neuroblastomas
- (2015) Alexander Schramm et al. NATURE GENETICS
- Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin
- (2015) Brian H. Kushner et al. Oncotarget
- ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
- (2014) Scott C. Bresler et al. CANCER CELL
- Immune-based therapies for childhood cancer
- (2014) Crystal L. Mackall et al. Nature Reviews Clinical Oncology
- Does Aggressive Surgical Resection Improve Survival in Advanced Stage 3 and 4 Neuroblastoma? A Systematic Review and Meta-analysis
- (2014) Dhanya Mullassery et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
- (2013) Yael P Mossé et al. LANCET ONCOLOGY
- Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients With Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641
- (2012) Douglas R. Strother et al. JOURNAL OF CLINICAL ONCOLOGY
- Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: A Pediatric Oncology Group study: A Report from the Children's Oncology Group
- (2012) Meaghan Granger et al. PEDIATRIC BLOOD & CANCER
- Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study
- (2011) Julie R. Park et al. JOURNAL OF CLINICAL ONCOLOGY
- NK Cell immunotherapy for high-risk neuroblastoma relapse after haploidentical HSCT
- (2011) Justyna Kanold et al. PEDIATRIC BLOOD & CANCER
- Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: A report from the International Neuroblastoma Risk Group Project
- (2010) Veronica Moroz et al. EUROPEAN JOURNAL OF CANCER
- Phase II Randomized Comparison of Topotecan Plus Cyclophosphamide Versus Topotecan Alone in Children With Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Study
- (2010) Wendy B. London et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival of Children With Neuroblastoma Between 1979 and 2005: A Report of the Italian Neuroblastoma Registry
- (2010) Riccardo Haupt et al. JOURNAL OF CLINICAL ONCOLOGY
- Accumulation of Segmental Alterations Determines Progression in Neuroblastoma
- (2010) Gudrun Schleiermacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Poor Survival for Infants WithMYCN-Amplified Metastatic Neuroblastoma Despite Intensified Treatment: The International Society of Paediatric Oncology European Neuroblastoma Experience
- (2009) Adela Canete et al. JOURNAL OF CLINICAL ONCOLOGY
- Increasing Incidence of Neuroblastoma and Potentially Higher Associated Mortality of Children From Nonmetropolitan Areas: Analysis of the Surveillance, Epidemiology, and End Results Database
- (2009) Michael H. Hsieh et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
- (2008) B De Bernardi et al. BRITISH JOURNAL OF CANCER
- Management and outcome of stage 3 neuroblastoma
- (2008) Shakeel Modak et al. EUROPEAN JOURNAL OF CANCER
- Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97
- (2008) Barbara Hero et al. JOURNAL OF CLINICAL ONCOLOGY
- High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial
- (2008) Andrew DJ Pearson et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now